96 related articles for article (PubMed ID: 2758679)
21. Apomorphine does not decrease tissue levels of tetrahydrobiopterin in vivo.
Bräutigam M; Kittner B; Herken H
Eur J Pharmacol; 1986 Aug; 127(1-2):143-6. PubMed ID: 3093252
[TBL] [Abstract][Full Text] [Related]
22. Molecular and enzymatic characterization of two enzymes BmPCD and BmDHPR involving in the regeneration pathway of tetrahydrobiopterin from the silkworm Bombyx mori.
Li W; Gong M; Shu R; Li X; Gao J; Meng Y
Comp Biochem Physiol B Biochem Mol Biol; 2015 Aug; 186():20-7. PubMed ID: 25899859
[TBL] [Abstract][Full Text] [Related]
23. [Hyperphenylalaninaemia with normal phenylalanine-hydroxylase activity and a deficiency of tetrahydrobiopterin and dihydropteridine reductase].
Rey F; Harpey JP; Leeming RJ; Blair JA; Aicardi J; Rey J
Arch Fr Pediatr; 1977; 34(7 Suppl):CIX-CXX. PubMed ID: 931522
[TBL] [Abstract][Full Text] [Related]
24. Identification of the 4-amino analogue of tetrahydrobiopterin as a dihydropteridine reductase inhibitor and a potent pteridine antagonist of rat neuronal nitric oxide synthase.
Werner ER; Pitters E; Schmidt K; Wachter H; Werner-Felmayer G; Mayer B
Biochem J; 1996 Nov; 320 ( Pt 1)(Pt 1):193-6. PubMed ID: 8947486
[TBL] [Abstract][Full Text] [Related]
25. Tetrahydrobiopterin and inherited hyperphenylalaninemias.
Blau N; Thony B; Spada M; Ponzone A
Turk J Pediatr; 1996; 38(1):19-35. PubMed ID: 8819618
[TBL] [Abstract][Full Text] [Related]
26. Tetrahydrobiopterin metabolism in the Rett disease.
Sahota A; Leeming R; Blair J; Hagberg B
Brain Dev; 1985; 7(3):249-50. PubMed ID: 4061756
[TBL] [Abstract][Full Text] [Related]
27. Endothelial nitric oxide synthase dysfunction in diabetic mice: importance of tetrahydrobiopterin in eNOS dimerisation.
Cai S; Khoo J; Mussa S; Alp NJ; Channon KM
Diabetologia; 2005 Sep; 48(9):1933-40. PubMed ID: 16034613
[TBL] [Abstract][Full Text] [Related]
28. 7-Tetrahydrobiopterin is an uncoupled cofactor for rat hepatic phenylalanine hydroxylase.
Davis MD; Kaufman S
FEBS Lett; 1991 Jul; 285(1):17-20. PubMed ID: 2065777
[TBL] [Abstract][Full Text] [Related]
29. Tetrahydrobiopterin is functionally distinguishable from tetrahydrodictyopterin in Dictyostelium discoideum Ax2.
Kim HL; Park MB; Park YS
FEBS Lett; 2011 Oct; 585(19):3047-51. PubMed ID: 21871890
[TBL] [Abstract][Full Text] [Related]
30. Mycophenolic acid simultaneously reduces intracellular GTP and tetrahydrobiopterin levels in neuro-2A cells.
Harada T; Hatakeyama K; Kagamiyama H
Adv Exp Med Biol; 1993; 338():183-6. PubMed ID: 8304106
[No Abstract] [Full Text] [Related]
31. Tetrahydrobiopterin reverses the impairment of acetylcholine-induced vasodilatation in diabetic ocular microvasculature.
Yu PK; Yu DY; Cringle SJ; Su EN
J Ocul Pharmacol Ther; 2001 Apr; 17(2):123-9. PubMed ID: 11324980
[TBL] [Abstract][Full Text] [Related]
32. Structural insights into the dual substrate specificities of mammalian and Dictyostelium dihydropteridine reductases toward two stereoisomers of quinonoid dihydrobiopterin.
Chen C; Kim HL; Zhuang N; Seo KH; Park KH; Han CD; Park YS; Lee KH
FEBS Lett; 2011 Sep; 585(17):2640-6. PubMed ID: 21819985
[TBL] [Abstract][Full Text] [Related]
33. An enzymatic method to distinguish tetrahydrobiopterin from oxidized biopterins using UDP-glucose:tetrahydrobiopterin glucosyltransferase.
Kim HL; Kim DH; Lee YK; Park SO; Lee YW; Kwon OS; Park YS
Anal Biochem; 2010 Feb; 397(1):79-83. PubMed ID: 19819217
[TBL] [Abstract][Full Text] [Related]
34. Malignant hyperphenylalaninemia--clinical features, biochemical findings, and experience with administration of biopterins.
Danks DM; Schlesinger P; Firgaira F; Cotton RG; Watson BM; Rembold H; Hennings G
Pediatr Res; 1979 Oct; 13(10):1150-5. PubMed ID: 503643
[TBL] [Abstract][Full Text] [Related]
35. Biopterin. V. De novo synthesis of dihydrobiopterin: evidence for its quinonoid structure and lack of dependence of its reduction to tetrahydrobiopterin on dihydrofolate reductase.
Gál EM; Bybee JA; Sherman AD
J Neurochem; 1979 Jan; 32(1):179-86. PubMed ID: 759569
[No Abstract] [Full Text] [Related]
36. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F
Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779
[TBL] [Abstract][Full Text] [Related]
37. Diminished expression of dihydropteridine reductase is a potent biomarker for hypertensive vessels.
Lee CK; Han JS; Won KJ; Jung SH; Park HJ; Lee HM; Kim J; Park YS; Kim HJ; Park PJ; Park TK; Kim B
Proteomics; 2009 Nov; 9(21):4851-8. PubMed ID: 19743417
[TBL] [Abstract][Full Text] [Related]
38. [Screening of tetrahydrobiopterin deficiency among hyperphenylalaninemic patients].
Dhondt JL; Hayte JM
Ann Biol Clin (Paris); 2002; 60(2):165-71. PubMed ID: 11937441
[TBL] [Abstract][Full Text] [Related]
39. [Early neurotoxicity of high-dose of methotrexate and tetrahydrobiopterin deficiency].
Netter JC; Dhondt JL; Rance F; Petrus M
Arch Fr Pediatr; 1991 Dec; 48(10):719-22. PubMed ID: 1793349
[TBL] [Abstract][Full Text] [Related]
40. Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease.
Alp NJ; Channon KM
Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):413-20. PubMed ID: 14656731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]